StemCell Therapy

LONDON, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today announced that Dr. Denise Scots-Knight, Chief Executive Officer, will participate in a Fireside Chat at the 2024 Cantor Global Healthcare Conference on Wednesday, September 18, 2024, at 10:55am ET / 03:55pm BST.

View original post here:
Mereo BioPharma to Participate in Fireside Chat at the 2024 Cantor Global Healthcare Conference

CARMEL, Ind., Sept. 12, 2024 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX) (“MBX Biosciences”), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced the pricing of its initial public offering of 10,200,000 shares of its common stock at a price to the public of $16.00 per share. The gross proceeds to MBX Biosciences from the offering, before deducting the underwriting discounts and commissions and offering expenses, are expected to be $163.2 million. All of the shares are being offered by MBX Biosciences. In addition, MBX Biosciences has granted the underwriters a 30-day option to buy an additional 1,530,000 shares of its common stock at the initial public offering price, less underwriting discounts and commissions.

Continue reading here:
MBX Biosciences Announces Pricing of Initial Public Offering

Basel, 13 September 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Tecentriq HybrezaTM (atezolizumab and hyaluronidase-tqjs), the first and only PD-(L)1 inhibitor for subcutaneous (SC), under the skin injection for patients in the United States. Tecentriq Hybreza can be injected subcutaneously over approximately seven minutes, compared with 30-60 minutes for standard intravenous (IV) infusion of Tecentriq (atezolizumab).2 It will be available for all IV indications of Tecentriq approved for adults in the U.S., including certain types of lung, liver, skin and soft tissue cancer.3

Excerpt from:
FDA approves Roche’s Tecentriq Hybreza, the first and only subcutaneous anti-PD-(L)1 cancer immunotherapy

Saint-Herblain (France), September 13, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) (“Valneva” or the “Company”), a specialty vaccine company, today announces the successful pricing of its Private Placement (as defined below) for a final amount of €61,180,000.

See the rest here:
Valneva Announces the Success of its Private Placement Raising approximately €60 Million

Tokyo, Japan and Cambridge and London, UK, 13 September 2024 – Nxera Pharma (TSE: 4565, “Nxera”) and Cancer Research UK announce an upcoming presentation on the ongoing Phase 1/2a clinical trial (NCT05944237) of Nxera’s immunotherapy drug HTL0039732 (also known as NXE0039732) at the European Society for Medical Oncology Congress (ESMO) 2024, taking place on 13–17 September in Barcelona, Spain.

More here:
Nxera’s Partner Cancer Research UK to Present on Phase 1/2a Clinical Trial with Cancer Immunotherapy Drug HTL0039732 at ESMO

Early vs Late Fast Window: Is One More Effective?  Medscape

View original post here:
Early vs Late Fast Window: Is One More Effective? - Medscape

Breakthrough T1D Walk to Cure Type 1 Diabetes  KATU

Read more:
Breakthrough T1D Walk to Cure Type 1 Diabetes - KATU

Foods That May Increase Kids' Risk of Type 1 Diabetes Revealed  Newsweek

Follow this link:
Foods That May Increase Kids' Risk of Type 1 Diabetes Revealed - Newsweek

Beds and Herts patients to be re-tested in diabetes results error  BBC.com

See the original post:
Beds and Herts patients to be re-tested in diabetes results error - BBC.com

This common habit increases your diabetes risk by 50%; Heres how to fix it  The Economic Times

Read more:
This common habit increases your diabetes risk by 50%; Heres how to fix it - The Economic Times

Elevated risk of pre-diabetes and diabetes in people with past history of COVID-19 in northeastern Nigeria  BMC Public Health

Original post:
Elevated risk of pre-diabetes and diabetes in people with past history of COVID-19 in northeastern Nigeria - BMC Public Health

Study links bananas, oats and yoghurt to greater diabetes risk in susceptible children  The Guardian

Continued here:
Study links bananas, oats and yoghurt to greater diabetes risk in susceptible children - The Guardian

Could the Norton research teams studying diabetes and Alzheimer's come up with a cure?  Courier Journal

Excerpt from:
Could the Norton research teams studying diabetes and Alzheimer's come up with a cure? - Courier Journal

Weight loss, better beta-cell function tied to long-term glycemic control with tirzepatide  Healio

See the article here:
Weight loss, better beta-cell function tied to long-term glycemic control with tirzepatide - Healio

Study finds weekly insulin injections as effective for diabetes as daily shots  UPI News

Read the original here:
Study finds weekly insulin injections as effective for diabetes as daily shots - UPI News

Ozempic, Wegovy, Rybelsus: Are we losing sight of overall health? Heres what the science says  The Conversation

See the article here:
Ozempic, Wegovy, Rybelsus: Are we losing sight of overall health? Heres what the science says - The Conversation

With once-a-week dosing, insulin efsitora alfa delivers similar A1C reduction compared to daily insulin in adults with type 1 diabetes  PR Newswire

Continue reading here:
With once-a-week dosing, insulin efsitora alfa delivers similar A1C reduction compared to daily insulin in adults with type 1 diabetes - PR Newswire

Dining with Diabetes workshops offered  The Courier-Express

View post:
Dining with Diabetes workshops offered - The Courier-Express

Researchers uncover connection between two common diabetes drugs with implications for foot ulcer healing  News-Medical.Net

See more here:
Researchers uncover connection between two common diabetes drugs with implications for foot ulcer healing - News-Medical.Net

The menopause can increase your likelihood of developing heart disease, type 2 diabetes and hypertension but exercise can help lower risk  The Conversation Indonesia

See more here:
The menopause can increase your likelihood of developing heart disease, type 2 diabetes and hypertension but exercise can help lower risk - The...